These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27458157)

  • 1. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
    Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
    Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZIC1 is a putative tumor suppressor in thyroid cancer by modulating major signaling pathways and transcription factor FOXO3a.
    Qiang W; Zhao Y; Yang Q; Liu W; Guan H; Lv S; Ji M; Shi B; Hou P
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1163-72. PubMed ID: 24684457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway.
    Fu J; Lv H; Guan H; Ma X; Ji M; He N; Shi B; Hou P
    BMC Cancer; 2013 Oct; 13():462. PubMed ID: 24098937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
    Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
    Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3.
    Lv Y; Sui F; Ma J; Ren X; Yang Q; Zhang Y; Guan H; Shi B; Hou P; Ji M
    Oncotarget; 2016 Sep; 7(36):57978-57990. PubMed ID: 27517321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways.
    Zhou Q; Chen J; Feng J; Xu Y; Zheng W; Wang J
    Mol Cell Biochem; 2017 Nov; 435(1-2):87-95. PubMed ID: 28551845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a.
    Qiang W; Sui F; Ma J; Li X; Ren X; Shao Y; Liu J; Guan H; Shi B; Hou P
    Endocrine; 2017 Apr; 56(1):98-108. PubMed ID: 28220348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.
    Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P
    Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
    Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
    Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
    Xiang S; Xiang T; Xiao Q; Li Y; Shao B; Luo T
    Int J Oncol; 2017 Sep; 51(3):801-811. PubMed ID: 28677721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
    Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
    Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX3 silencing suppresses gastric cancer proliferation and angiogenesis via MET/PI3K signaling.
    Lv WL; Hu YY; Li ZN; Zhang W; Pan Q
    Neoplasma; 2020 Mar; 67(2):304-311. PubMed ID: 31847528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO3a: a novel player in thyroid carcinogenesis?
    Karger S; Weidinger C; Krause K; Sheu SY; Aigner T; Gimm O; Schmid KW; Dralle H; Fuhrer D
    Endocr Relat Cancer; 2009 Mar; 16(1):189-99. PubMed ID: 18845647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies.
    Marlow LA; von Roemeling CA; Cooper SJ; Zhang Y; Rohl SD; Arora S; Gonzales IM; Azorsa DO; Reddi HV; Tun HW; Döppler HR; Storz P; Smallridge RC; Copland JA
    J Cell Sci; 2012 Sep; 125(Pt 18):4253-63. PubMed ID: 22718346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GFAP expression is regulated by Pax3 in brain glioma stem cells.
    Su X; Liu X; Ni L; Shi W; Zhu H; Shi J; Chen J; Gu Z; Gao Y; Lan Q; Huang Q
    Oncol Rep; 2016 Sep; 36(3):1277-84. PubMed ID: 27432276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
    Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
    Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF677 Suppresses Akt Phosphorylation and Tumorigenesis in Thyroid Cancer.
    Li Y; Yang Q; Guan H; Shi B; Ji M; Hou P
    Cancer Res; 2018 Sep; 78(18):5216-5228. PubMed ID: 29997231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.